8-K: HealthEquity Q1 2027 Results and Guidance Raise

HealthEquity reported strong Q1 2027 financial results, featuring a 29% increase in net income and an increased fiscal year outlook.

Summary

• Revenue grew 7% year-over-year to $354.6 million for the first quarter ended April 30, 2026.
• Net income rose 29% to $69.4 million, with net income margin expanding to 20% from 16% in the prior year period.
• Adjusted EBITDA increased 17% to $164.5 million, representing a 46% margin compared to 42% last year.
• Total HSA assets grew 19% to $37.1 billion, supported by 10.6 million HSA accounts.
• The company returned $123.0 million to shareholders through stock repurchases during the quarter.

Sentiment

Score: 9

Explanation: StockSavvy.ai views this as a highly positive report, characterized by strong margin expansion, double-digit asset growth, and a significant increase in the share repurchase authorization, signaling management's confidence in future cash flows.

Positives

• Net income per diluted share increased 34% to $0.82.
• Adjusted EBITDA margin expanded significantly to 46%.
• Total HSA assets reached a record $37.1 billion.
• Management raised the fiscal 2027 financial outlook.
• Board authorized an additional $1.0 billion for the share repurchase program.

Negatives

• Cash and cash equivalents decreased to $265.4 million from $318.9 million at the start of the fiscal year.
• Accumulated other comprehensive loss increased to $31.8 million from $5.7 million due to cash flow hedge activity.

Risks

• Dependence on the continued availability and tax-advantaged status of HSAs and other consumer-directed benefits.
• Exposure to potential fraudulent account activity impacting reputation and financial results.
• Reliance on third-party depository and insurance partners for custodial assets.
• Intense competition in the healthcare benefits administration industry.
• Cybersecurity risks related to technology platforms and data storage.

Future Outlook

For fiscal year 2027, management expects revenue between $1.410 billion and $1.420 billion, with Adjusted EBITDA projected at $625 million to $633 million. Non-GAAP net income per diluted share is expected to be between $4.66 and $4.73.

Management Comments

• HealthEquity delivered strong first quarter results, with Adjusted EBITDA margin expanding to 46% and a raised fiscal 2027 outlook.
• These results demonstrate that our flywheel is compounding through account and asset growth, deeper member engagement, technology-enabled efficiency, and increasing operating leverage.
• Our authorization of an additional $1 billion under our share repurchase program reflects our confidence in the durability and long-term cash-generating power of our model.

Industry Context

StockSavvy.ai notes that HealthEquity continues to solidify its position as the largest independent HSA custodian. The company's focus on 'flywheel' compounding—leveraging account growth and member engagement—aligns with broader industry trends where healthcare financial responsibility is increasingly shifting toward the consumer, driving demand for integrated HSA and CDB platforms.

Comparison to Industry Standards

• The 46% Adjusted EBITDA margin is highly competitive within the financial services and benefits administration sector.
• The 19% growth in HSA assets outpaces general market growth for consumer-directed healthcare accounts.
• The company's scale (17.8 million total accounts) provides a significant moat compared to smaller regional benefits administrators.

Corporate Governance

Stakeholder Impact

• Shareholders benefit from the $1.0 billion share repurchase authorization.
• Clients and members benefit from continued investment in technology-enabled efficiency and platform features.

Next Steps

• Host conference call on May 28, 2026.
• Execute share repurchases under the newly authorized $1.0 billion program.

Key Dates

Recommendation

The combination of strong margin expansion, consistent asset growth, and a significant increase in share buybacks makes the stock attractive for investors seeking exposure to the growing consumer-directed healthcare market.

Keywords

HealthEquity, HSA, Health Savings Account, Consumer-directed benefits, HQY, Financial results, Earnings